93654-27-4 Usage
Description
6-Chloro-2-oxo-4-phenyl-1,2-dihydro-quinoline-3-carboxylic acid ethyl ester is a chemical compound belonging to the quinoline class, featuring a chloro group at the 6 position and a phenyl group at the 4 position. As an ester derivative of quinoline-3-carboxylic acid, it possesses structural features that may contribute to its biological activity, making it a promising candidate for pharmaceutical applications.
Uses
Used in Pharmaceutical Industry:
6-Chloro-2-oxo-4-phenyl-1,2-dihydro-quinoline-3-carboxylic acid ethyl ester is used as a building block in the synthesis of other pharmaceutical compounds due to its unique structural features.
It is also considered a potential drug candidate for the treatment of various diseases, given its potential biological activity and the interest it has garnered in the pharmaceutical industry for further research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 93654-27-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,3,6,5 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 93654-27:
(7*9)+(6*3)+(5*6)+(4*5)+(3*4)+(2*2)+(1*7)=154
154 % 10 = 4
So 93654-27-4 is a valid CAS Registry Number.
93654-27-4Relevant articles and documents
Synthesis and biological evaluation of dihydroquinoline carboxamide derivatives as anti-tubercular agents
Kumar, Gautam,Sathe, Asawari,Krishna, Vagolu Siva,Sriram, Dharmarajan,Jachak, Sanjay M.
, p. 1 - 13 (2018/08/01)
Sodium trifluoromethanesulfonate, and glacial acetic acid selectively catalyzed the synthesis of dihydroquinoline via Friedl?nder annulation. The synthesized dihydroquinoline analogues coupled with different amines by the use of coupling reagent gave dihy
METHODS AND COMPOSITIONS FOR INHIBITION OF BROMODOMAIN-CONTAINING PROTEINS
-
Page/Page column 77, (2014/10/15)
The present invention relates to compounds that bind to and otherwise modulate the activity of bromodomain-containing proteins, to processes for preparing these compounds, to pharmaceutical compositions containing these compounds, and to methods of using these compounds for treating a wide variety of conditions and disorders.
NEW ARYL-QUINOLINE DERIVATIVES
-
Page/Page column 59-60, (2013/05/22)
The invention provides novel compounds having the general formula (I), wherein R1, R2, R3, R4 R5, R6 and n are as described herein, compositions including the compounds and methods of using the compounds.
